Genetics and Epigenetics of FASD

Baker, Jessica A.; Yu, Shuliang; Scott, Matthew T.; Hamre, Kristin

doi:10.1007/978-3-031-20792-1_27

Cited by 1 publication

(1 citation statement)

References 97 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nevertheless, functional solutions have been proposed, including the definition of biomarkers that can distinguish between these diseases, which may contribute to both correct diagnosis and selection of appropriate therapy, and also it could play a role in tracking patient status [12,13]. The promising biomarkers are described in different psychiatric disorders and include alterations in the genetic, epigenetic, structure, function of the brain, endocrine system, immune system, and neuropsychological aspects [13,14,15,16].It is widely accepted that social phobia is a polygenic and complex condition, however, few altered genetic and epigenetic factors are identified as causative agents.…”

Section: Introductionmentioning

confidence: 99%

Serotonin-related Mechanisms in the Etiology and Pharmacotherapy of Social Phobia, A Review: Serotonin and Social Phobia

Arjmandi Ghandashtani,

Poudineh,

Sarlak

et al. 2023

GMJ

View full text Add to dashboard Cite

Social anxiety disorder (SAD), known as social phobia, is considered a prevalent psychiatric disorder characterized by a constant fear of social positions. Frequently, social phobia occurs with other mental disorders including depression and substance abuse conditions. Although SAD is considered one of the most common types of mental disorders, proper management may be compromised in recurrent psychiatric comorbidity due to clinicians’ focus on secondary complications. Moreover, despite the description of social phobia as a polygenic and complex condition, few altered genetic and epigenetic factors are identified as causative agents. Over the past decades, several studies have suggested polymorphisms in serotonergic and dopaminergic-related genes as the etiology of social phobia. Serotonin, on the other hand, as a necessary neurotransmitter in the central nervous system (CNS), is involved in a variety of disease processes including social phobia. Nevertheless, the exact mechanism of serotonin-dependent development of the disease and the efficacy of suggested pharmacotherapies are not fully understood. The current study aimed to review the serotonin-dependent mechanisms by which SAD develops and discuss the current suggested strategies that are based on serotonin metabolism.

show abstract